Answers are grounded in this paper and cite their sources.
(K2P) superfamily, sits at the intersection of the two as a physiologically relevant target of both volatile and intravenous anesthetics. Although the direct interaction of anesthetics with TREK-1 protein has been studied extensively, how membrane lipid composition and lipid-driven conformational dynamics modulate channel gating remains insufficiently explored. In this review, we synthesize evidence retrieved from PubMed, PubMed Central, Web of Science, Scopus, Embase, the Cochrane Library, and ClinicalTrials.gov (1996-April 2025) to examine how the physicochemical properties of the lipid bilayer - cholesterol content, phosphatidylinositol-4,5-bisphosphate (PIP2) abundance, lysophospholipids, and membrane tension - collectively govern TREK-1 activity in anesthetic contexts. Converging data from structural biology, electrophysiology, computational modeling, and animal studies indicate that anesthetics alter bilayer fluidity, reshape the lateral pressure profile, and displace lipid ligands such as PIP2 and arachidonic acid from defined sites on TREK-1, thereby tuning channel open probability through a bidirectional lipid-protein allosteric axis that links membrane dynamics to fenestration and selectivity-filter conformations; consistently, TREK-1 knockout and lipid depletion each attenuate anesthetic sensitivity in vivo. We argue that membrane lipids are not passive bystanders but active modulators of the TREK-1 gating landscape, and that integrating this lipid dimension - through cryo-EM, molecular dynamics simulations, and patient-derived membrane lipidomics - may enable isoform-selective drug design and help explain interindividual variability in anesthetic sensitivity.
No takes yet. Share an insight, caveat, or question.
Bai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: